Optineurin Functions for Optimal Immunity
Authors:
Open Access
- 10 April 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 769
Abstract
Optineurin (OPTN) was identified 20 years ago in a yeast-two-hybrid screen with a viral protein known to inhibit the cytolytic effects of tumor necrosis factor. Since then, OPTN has been identified as a ubiquitin-binding protein involved in many signaling pathways and cellular processes, and mutations in the OPTN gene have been associated with glaucoma, Paget’s disease of bone and neurodegenerative pathologies. Its role in autophagy, however, has attracted most attention in recent years and may explain (some of) the mechanisms behind the disease-associated mutations of OPTN. In this brief review, we focus on the role of OPTN in inflammation and immunity and describe how this may translate to its involvement in human disease.Keywords
This publication has 44 references indexed in Scilit:
- Polyubiquitin Binding to Optineurin Is Required for Optimal Activation of TANK-binding Kinase 1 and Production of Interferon βJournal of Biological Chemistry, 2011
- Optineurin Is Required for CYLD-Dependent Inhibition of TNFα-Induced NF-κB ActivationPLOS ONE, 2011
- Autophagy in immunity and inflammationNature, 2011
- The majority of the genetic risk for Paget’s disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genesHuman Genetics, 2010
- Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of boneNature Genetics, 2010
- Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in miceHuman Molecular Genetics, 2010
- Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's diseaseJournal of Experimental Medicine, 2009
- Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's diseaseJournal of Experimental Medicine, 2009
- NF-κB Mediates Tumor Necrosis Factor α-Induced Expression of Optineurin, a Negative Regulator of NF-κBPLOS ONE, 2009
- Optineurin Negatively Regulates TNFα- Induced NF-κB Activation by Competing with NEMO for Ubiquitinated RIPCurrent Biology, 2007